M3, Inc.

Tokyo Stock Exchange 2413.T

M3, Inc. EBITDA for the year ending March 31, 2024: USD 516.07 M

M3, Inc. EBITDA is USD 516.07 M for the year ending March 31, 2024, a -11.93% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • M3, Inc. EBITDA for the year ending March 31, 2023 was USD 585.97 M, a -3.14% change year over year.
  • M3, Inc. EBITDA for the year ending March 31, 2022 was USD 604.94 M, a 4.55% change year over year.
  • M3, Inc. EBITDA for the year ending March 31, 2021 was USD 578.62 M, a 58.97% change year over year.
  • M3, Inc. EBITDA for the year ending March 31, 2020 was USD 363.97 M, a 38.25% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
Tokyo Stock Exchange: 2413.T

M3, Inc.

CEO Mr. Itaru Tanimura
IPO Date Sept. 16, 2004
Location Japan
Headquarters Akasaka Intercity
Employees 12,100
Sector Health Care
Industries
Description

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Similar companies

7741.T

HOYA Corporation

USD 128.19

-0.84%

6098.T

Recruit Holdings Co., Ltd.

USD 67.26

-3.14%

4543.T

Terumo Corporation

USD 18.93

-0.22%

6861.T

Keyence Corporation

USD 393.06

-2.27%

6594.T

Nidec Corporation

USD 18.08

-2.14%

StockViz Staff

January 15, 2025

Any question? Send us an email